Research.Patient.info
recurrent prostate cancer research hub
2 indexed studies · 2 currently recruiting
- recruitingTherapeutic exploratory (Phase II)
Radiotherapy in combination with pembrolizumab in patients with PSA persistence or biochemical recurrence after radical prostatectomy due to prostate cancer - Pembro-SRT
This study looks at combining radiotherapy with an immunotherapy medicine called pembrolizumab (Keytruda) for men with prostate cancer. It is for people whose PSA levels stay detectable or begin rising again after surgery to remove the prostate. Researchers want to see if this combination safely clears the cancer.
Germany - recruitingPHASE1, PHASE2
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
This study is testing a new light-based treatment for men with prostate cancer that has come back. It uses a special light system called SpectraCure P18 and a drug called verteporfin to see if it's safe and helps shrink the cancer.
United States · Canada · Sweden